Stockreport

Silence Therapeutics: Divesiran Targets High-Burden PV [Seeking Alpha]

Silence Therapeutics Plc - American Depository Share  (SLN) 
PDF SLN boasts a strong cash position ($100M+), providing runway through 2028 and enabling continued pipeline development without near-term financing risks. The SANRECO t [Read more]